Acolyte™ System
Coronary Chronic Total Occlusions (CTO)
Pre-clinicalActive
Key Facts
About Elumn8 Medical
Elumn8 Medical is targeting the challenging market of coronary chronic total occlusions (CTOs) with its novel Acolyte™ System. The company, founded by renowned interventional cardiology pioneer Dr. John B. Simpson, is developing a first-of-its-kind combination device intended to integrate imaging and crossing capabilities to improve procedural success and adoption. With over 250,000 CTOs diagnosed annually in the US and a vast undertreated patient population, Elumn8 is positioned to address a major clinical gap. Its success hinges on demonstrating the efficacy and ease-of-use of its platform to drive adoption beyond the limited number of highly specialized operators currently performing CTO-PCI.
View full company profile